THOUSANDS of men with low-risk prostate cancer will be spared gruelling ops and radiotherapy by new NHS guidance.
The National Institute for Health and Care Excellence now recommends telling patients there is no difference to ten-year survival rates either with or without the treatments.
Getty – Contributor Some 7,800 men are diagnosed with low-risk prostate cancer each year in the UK
The 7,800 men a year diagnosed with low-risk prostate cancer will instead get “active surveillance” known as “watch and wait”.
Patients will be monitored for changes with regular MRI scans — 12 per cent better than standard tests.
HARD TO SWALLOW You can get throat gonorrhoea from KISSING – the signs you need to know NEW HOPE Student’s face engulfed by deadly birthmark has 20 operations to rebuild her face OP SHOCK Penis enlargement ops don’t work and could leave it SHORTER, experts warn BLOOMING HELL Hay fever will blight 30 million Brits by 2030 as pollen count set to surge SMEAR FEARS Millions miss out on cervical cancer checks as NHS ‘loses grip’ on smear tests
Experts claim it could prevent thousands from having ops such as prostate removal which can lead to impotence and incontinence.
Prostate Cancer UK’s Heather Blake said: “What is crucial is active surveillance is consistently delivered to a high standard across the UK alongside personalised information and support.”
GP Sam Merriel welcomed the changes but cautioned: “Choosing active surveillance is not easy as it goes against the natural instinct of wanting to get rid of the cancer immediately.”
Paddy Doherty, 60, is battling prostate cancer and considered suicide twice as pain was so bad